These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26054706)

  • 21. Axillary reverse lymphatic mapping in breast cancer surgery: a comprehensive review.
    Seyednejad N; Kuusk U; Wiseman SM
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):771-81. PubMed ID: 24621187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
    Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
    Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
    J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
    Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Che Bakri NA; Kwasnicki RM; Khan N; Ghandour O; Lee A; Grant Y; Dawidziuk A; Darzi A; Ashrafian H; Leff DR
    Ann Surg; 2023 Apr; 277(4):572-580. PubMed ID: 35946806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
    Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
    Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
    Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K
    Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
    J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
    Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two decades of axillary management in breast cancer.
    Beek MA; Verheuvel NC; Luiten EJ; Klompenhouwer EG; Rutten HJ; Roumen RM; Gobardhan PD; Voogd AC
    Br J Surg; 2015 Dec; 102(13):1658-64. PubMed ID: 26694991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.